LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $34,000 | +21.4% | 13,000 | 0.0% | 0.00% | – |
| Q1 2018 | $28,000 | +16.7% | 13,000 | 0.0% | 0.00% | – |
| Q4 2017 | $24,000 | +4.3% | 13,000 | 0.0% | 0.00% | – |
| Q3 2017 | $23,000 | +4.5% | 13,000 | 0.0% | 0.00% | – |
| Q2 2017 | $22,000 | -99.4% | 13,000 | -99.5% | 0.00% | -100.0% |
| Q1 2017 | $3,698,000 | -17.4% | 2,465,000 | -16.9% | 0.00% | -20.0% |
| Q4 2016 | $4,477,000 | +3.5% | 2,965,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $4,324,000 | -13.8% | 2,965,000 | 0.0% | 0.01% | -16.7% |
| Q2 2016 | $5,015,000 | +14.3% | 2,965,000 | 0.0% | 0.01% | +20.0% |
| Q1 2016 | $4,389,000 | -6.1% | 2,965,000 | -1.2% | 0.01% | 0.0% |
| Q4 2015 | $4,674,000 | +18.6% | 3,000,000 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $3,941,000 | – | 3,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opera Trading Capital | 5,700,000 | $8,208,000 | 2.47% |
| TFG Asset Management GP Ltd | 8,100,000 | $11,729,000 | 2.33% |
| Mint Tower Capital Management B.V. | 4,500,000 | $6,507,000 | 2.17% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,010,000 | $11,584,000 | 1.75% |
| CQS Cayman LP | 15,000,000 | $21,717,000 | 1.72% |
| LINDEN ADVISORS LP | 21,855,000 | $31,633,000 | 1.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,575,000 | $32,593,000 | 0.92% |
| Myriad Asset Management Ltd. | 9,000,000 | $13,045,000 | 0.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,000,000 | $36,172,000 | 0.64% |
| CSS LLC/IL | 5,500,000 | $7,955,000 | 0.43% |